Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tatiana Klitochenko"'
Autor:
Olga Senderova, Gysual Safuanova, Andrey Zaritsky, Elza Lomaia, Anton Kulikovsky, Elena Fedorova, Alexandr Korobkin, Marina Kozmina, Lubov Gavrilova, Eva Burnasheva, Elena Volodicheva, Galina Kuchma, Alexander S. Luchinin, Ludmila Napso, Dolgorzhap Dasheeva, Varvara I. Bakhtina, Ekaterina Chelysheva, Anna Lyamkina, Anton Shutilev, Marina Kosinova, Anatoly Golenkov, Vasilisa Skatova, Olga V. Lazareva, Svetlana Volkova, Sergei M. Kulikov, Tatiana Konstantinova, Sergey Voloshin, Vera Yablokova, Tatiana Klitochenko, Anna G. Turkina, Andrew Proidakov, Nataliya Glonina, Andrew Zhuravkov, Tatiana Chagorova, Olga Vinogradova
Publikováno v:
Blood. 138:5035-5035
The results of long-term follow-up of patients (pts) with chronic myeloid leukemia (CML) do not lose their importance. Data from routine clinical practice are of particular interest. The use of 1 st (imatinib, IM) and 2nd generation TKI (2G TKI) led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a19128c61306200bf830a0b28868e780
https://doi.org/10.1182/blood-2021-151371
https://doi.org/10.1182/blood-2021-151371
Autor:
Mironov Oleg I, Elena Volodicheva, Raisa Minullina, Elena G. Smirnova, Gulnara Husainova, Tatyana Ionova, Tatiana Shelekhova, Olga Larionova, Vyacheslav Kurakin, Oksana Kaverina, Iurii Osipov, Alim Amdiev, Mikhail Yu Volkov, NE Mochkin, N. Mikhailova, V. E. Ivanov, Natalia Trenina, Dmitrij Sherstnev, Oleg Rykavitcin, Tatiana Nikitina, Polina Simashova, E A Baryakh, Viktor Chang, Kirill V. Lepik, Darya Lazareva, Boris V. Afanasiev, Evgeniy V. Vasiliev, Elena N. Misyurina, Irina Lysenko, Maria Andrievskih, K D Kaplanov, Tatiana Klitochenko, Rustem Safin, Tatiana V. Petrova, Natalia Porfirieva
Publikováno v:
Blood. 134:5296-5296
There is a continued unmet medical need in pts with relapsed/refractory Hodgkin's lymphoma (RR HL). Curing HL pts who have refractory disease after salvage chemotherapy, who relapse after ASCT, or those who are not candidates for ASCT, remains a clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::852fbc2b794b614e5d87a8b7e8011b31
https://doi.org/10.1182/blood-2019-121997
https://doi.org/10.1182/blood-2019-121997
Autor:
Tatiana Klitochenko, Olga Senderova, Anatoly Golenkov, Anna G. Turkina, Irina Krylova, Lyudmila Napso
Publikováno v:
Blood. 126:5156-5156
Introduction: in the last 10 years the number of tyrosine kinase inhibitors (TKI) used to treat patients with chronic myeloid leukemia (CML) significantly increased. The basic principle of therapy was also changed, now it is aimed at early induction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58b42fbc650743b6ded38edabc3ba024
https://doi.org/10.1182/blood.v126.23.5156.5156
https://doi.org/10.1182/blood.v126.23.5156.5156